Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 3 Item

Tebentafusp in metastatic uveal melanoma

Tebentafusp in metastatic uveal melanoma
Tebentafusp, a bispecific protein, consists of a soluble affinity-enhanced T-cell receptor fused to an anti-CD3 effector that can direct T cells to target glycoprotein 100-positive cells.
HLA: human leukocyte antigen; CD3: cluster of differentiation 3.
From: Nathan P, Hassel JC, Rutkowski P, et al. Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med. 2021 Sep 23;385(13):1196-1206. Copyright © 2021 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.
Graphic 135190 Version 1.0

Do you want to add Medilib to your home screen?